Breakthrough Picodya R&D program gains IIA approval


Picodya Technologies Ltd. receives approval for its development program from the Israeli Innovation Authority, which will now provide financial support for the further advancement of Picodya’s biochemical diagnostic technology and system for point-of-care immunoassay testing.

Contact Us

If you’re interested in Picodya and learning more about our game-changing B-Matrix™ technology, simply enter your details below. We’ll be happy to share further details and discuss our vision for better, cheaper, more accessible diagnostics worldwide.